Four key trends reshaping strategic M&A in biopharma. This and more in this week’s life sciences industry update. … READ MORE >
Blog
Is Kevin Warsh a man for all seasons, or a chameleon?
RSM Chief Economist Joe Brusuelas offered his thoughts on the nomination of Kevin Warsh to become the next Federal Reserve chair. … READ MORE >
Market Minute: Recent losses signal further dollar weakness
The dollar’s fall below its most recent trading range and below its five-year moving average suggests the potential for continued weakness. … READ MORE >
Market Minute: Revising our Fed rate call and our growth scenarios
We are updating our FOMC rate forecast to expect one 25 basis-point rate cut this year, either at the July or September meeting. … READ MORE >
Fed puts rate cuts on pause until further notice
Should the economy outperform this year, then the risk is not around rate cuts but rather no cut at all or even a late-year increase. … READ MORE >
Bank of Canada holds interest rate again—and may stay put this year
The Bank of Canada maintained its key interest rate at 2.25 per cent. At this juncture—all things being equal—we do not expect the central bank to change its policy rate this year. … READ MORE >
Market Minute: Geopolitical tensions and the cost of capital
Recent moves in interest rates and currency valuations point to growing concern over the reliability of the United States as a trade partner and financier. … READ MORE >
Health care industry trend watch: Week of Jan. 26, 2026
Telehealth uncertainty: How can providers protect access and stability? This and more in this week’s trend watch. … READ MORE >
Consumer confidence plunges to lowest level since 2014
The Conference Board’s index fell to 84.5, missing the consensus forecast of 90.0 and marking the lowest reading since May 2014. … READ MORE >
Market Minute: Volatility in financial markets
Volatility became part of the fabric in the financial markets in the past year, with the equity and bond markets reacting to repeated crises. … READ MORE >









